Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1)
Condition(s):HIV InfectionsLast Updated:November 28, 2023Completed
Hide Studies Not Open or Pending
Condition(s):HIV InfectionsLast Updated:November 28, 2023Completed
Condition(s):HIV InfectionsLast Updated:November 28, 2023Completed
Condition(s):HIV InfectionsLast Updated:February 15, 2024Active, not recruiting
Condition(s):HIV InfectionsLast Updated:January 8, 2024Active, not recruiting
Condition(s):Infection, Human Immunodeficiency Virus; HIV InfectionsLast Updated:January 30, 2020Completed
Condition(s):Infection, Human Immunodeficiency Virus ILast Updated:November 2, 2018Terminated
Condition(s):HIV-1 InfectionLast Updated:May 23, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.